Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
538,187
-
Shares change
-
+66,513
-
Total reported value, excl. options
-
$357,812
-
Value change
-
+$45,282
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$0.6648
Significant Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q3 2025
21 filings reported holding IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK as of Q3 2025.
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 538,187 shares
.
Largest 10 shareholders include BlackRock, Inc. (252,730 shares), VANGUARD GROUP INC (102,905 shares), GEODE CAPITAL MANAGEMENT, LLC (45,109 shares), TWO SIGMA INVESTMENTS, LP (31,500 shares), TWO SIGMA SECURITIES, LLC (28,441 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20,962 shares), UBS Group AG (20,088 shares), STATE STREET CORP (11,797 shares), Mason & Associates Inc (10,000 shares), and MORGAN STANLEY (9,266 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.